Bellinger L L, Bernardis L L
Peptides. 1984 May-Jun;5(3):547-52. doi: 10.1016/0196-9781(84)90085-8.
Rats with dorsomedial hypothalamic lesions (DMN-L) or sham operations were injected IP with saline or the satiety peptide cholecystokinin (CCK) at 3.0 and 6.0 micrograms/kg at the onset of the dark phase. Food consumption was then measured 15, 30 and 60 min later. Compared to saline baseline intake, CCK suppressed feeding during the first 30 min following injection in the sham operated group but not in the DMN-L group. Bombesin (BBS), another satiety peptide was also injected (4.0 and 8.0 micrograms/kg) into the two groups. BBS produced significant and comparable suppression of feeding in both DMN-L and sham operated rats. In a third trial a large dose of CCK (12.0 micrograms/kg) was injected into the two groups as described above. The CCK suppressed feeding for 60 min in the control group. CCK also attenuated feeding in the DMN-L group, but for only 30 min. However, even this suppression was reduced compared to the control group. The data suggest that the DMN may play a role in CCK induced satiety.
对患有下丘脑背内侧损伤(DMN-L)的大鼠或进行了假手术的大鼠,在黑暗期开始时腹腔注射生理盐水或3.0微克/千克和6.0微克/千克的饱腹感肽胆囊收缩素(CCK)。然后在15分钟、30分钟和60分钟后测量食物摄入量。与生理盐水基线摄入量相比,在假手术组中,CCK在注射后的前30分钟内抑制了进食,但在DMN-L组中没有。另一种饱腹感肽蛙皮素(BBS)也被注射到两组中(4.0微克/千克和8.0微克/千克)。BBS在DMN-L组和假手术组大鼠中均产生了显著且相当的进食抑制作用。在第三次试验中,如上述那样向两组注射大剂量的CCK(12.0微克/千克)。CCK在对照组中抑制进食60分钟。CCK在DMN-L组中也减弱了进食,但仅持续30分钟。然而,与对照组相比,即使这种抑制作用也有所降低。数据表明,DMN可能在CCK诱导的饱腹感中起作用。